Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 260, Issue 1-2, Pages 132-138Publisher
ELSEVIER
DOI: 10.1016/j.jns.2007.04.017
Keywords
N-acethylaspartate; BPSD; MRS; myoinositol; Alzheimer's disease; cognitive impairment; cingulate gyri
Categories
Ask authors/readers for more resources
Background and purpose: The cognitive decline in Alzheimer's disease (AD) patients has been reported to involve alterations in the medial temporal lobe and the posterior cingulate gyrus. On the other hand, the neurochemical pathologies of the behavioral and psychological symptoms of dementia (BPSD) have not been sufficiently discussed. The aim of this study was to clarify the pathologies of BPSD in AD patients. Methods: Thirty patients with probable AD were included and underwent the following assessments: Mini Mental State Examination (MMSE), Clock Drawing Test (CDT), Story Recall Test (SRT), Behavioral pathology in Alzheimer's disease (BEHAVE-AD) and proton MRS (H-1-MRS). None of them had been medicated for BPSD. Results: The MRS study revealed that MMSE, CDT, and SRT scores were positively related to N-acetyl-aspartate (NAA)/creatine(Cr) and negatively related to myoinositol (ml)/Cr in the posterior cingulate gyrus, but not in the anterior cingulate gyrus. On the other hand, the scores obtained in two categories of BEHAVE-AD (delusional thought/ activity disturbances) were negatively related with NAA/Cr and positively related with ml/Cr in the anterior cingulate gyrus, but not in the posterior cingulate gyrus. Conclusion: We conclude that BPSD and the decline in cognitive function in AD might have separate pathologies. (C) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available